Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 3, 2026 · Item 5.07
CRESCENT BIOPHARMA, INC.
6
Item 5.07
Jun 3, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Item 5.07 |
| Primary topic | Item 5.07 |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | CRESCENT BIOPHARMA, INC. filed this 8-K to disclose: ) 300 Fifth Avenue Waltham , MA 02451 (Address of Principal Executive Offices) (Zip Code) Registrant’s telephone number, including area code: ( 617 ) 430-5595 Not applicable (Former Name or Former Address, if Changed Since Last Report) ________________________________________________________________________________________________ Check the appropriate box b… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 2, 2026 |
| Accession number | 0001628280-26-040051 |
| Reported items | Item 5.07 See Analysis tab for workforce implications |
